Wall Street Zen upgraded shares of Core Laboratories (NYSE:CLB – Free Report) from a sell rating to a hold rating in a research note released on Sunday.
Separately, Weiss Ratings lowered shares of Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Core Laboratories currently has a consensus rating of “Hold” and an average price target of $12.00.
View Our Latest Stock Analysis on Core Laboratories
Core Laboratories Trading Down 0.1%
Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. The company had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The firm’s revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Equities research analysts forecast that Core Laboratories will post 0.57 earnings per share for the current fiscal year.
Core Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Monday, May 11th will be given a dividend of $0.01 per share. The ex-dividend date is Monday, May 11th. This represents a $0.04 annualized dividend and a yield of 0.3%. Core Laboratories’s dividend payout ratio (DPR) is currently 6.15%.
Institutional Investors Weigh In On Core Laboratories
Several hedge funds have recently added to or reduced their stakes in the business. State of Wyoming boosted its position in Core Laboratories by 267.7% during the 1st quarter. State of Wyoming now owns 4,626 shares of the oil and gas company’s stock worth $78,000 after buying an additional 3,368 shares during the period. Dimensional Fund Advisors LP boosted its position in Core Laboratories by 10.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,352,329 shares of the oil and gas company’s stock worth $22,705,000 after buying an additional 122,718 shares during the period. Heartland Advisors Inc. acquired a new stake in Core Laboratories during the 1st quarter worth approximately $2,518,000. Illinois Municipal Retirement Fund boosted its position in Core Laboratories by 12.9% during the 1st quarter. Illinois Municipal Retirement Fund now owns 25,642 shares of the oil and gas company’s stock worth $431,000 after buying an additional 2,930 shares during the period. Finally, Fifth Third Bancorp boosted its position in Core Laboratories by 2,397.6% during the 1st quarter. Fifth Third Bancorp now owns 11,414 shares of the oil and gas company’s stock worth $192,000 after buying an additional 10,957 shares during the period. 97.81% of the stock is currently owned by institutional investors and hedge funds.
Core Laboratories Company Profile
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Further Reading
- Five stocks we like better than Core Laboratories
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
